Vermillion Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.62M Sell
1,404
-1,549
-52% -$1.83M 1.86% 11
2026
Q2
$3.54M Sell
2,953
-398
-12% -$407K 0.83% 23
2026
Q1
$3.08M Buy
3,351
+208
+7% +$211K 1.21% 15
2025
Q4
$3.38M Buy
3,143
+159
+5% +$152K 1.37% 13
2025
Q3
$2.28M Buy
2,984
+162
+6% +$121K 0.62% 28
2025
Q2
$2.2M Sell
2,822
-2,494
-47% -$1.94M 1.05% 15
2025
Q1
$4.39M Buy
5,316
+3
+0.1% +$2.5K 1.29% 18
2024
Q4
$4.1M Buy
+5,313
New +$4.4M 2.1% 11

Other funds holding LLY

Vermillion Wealth Management's LLY Position: Q3 2026 in Review

Vermillion Wealth Management reduced its Eli Lilly (LLY) stake by 52% in Q3 2026, selling an estimated $1.83M and leaving 1,404 shares worth $1.62M. The position accounts for 1.86% of the portfolio, ranked #11.

Vermillion Wealth Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $4.39M in Q1 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vermillion Wealth Management held 1,404 shares of Eli Lilly worth $1.62M as of Q3 2026.
  • Vermillion Wealth Management sold 1,549 Eli Lilly shares in Q3 2026, an estimated $1.83M.
  • Eli Lilly made up 1.86% of Vermillion Wealth Management's portfolio in Q3 2026, its #11 holding.
  • Vermillion Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Vermillion Wealth Management's Eli Lilly position peaked at $4.39M in Q1 2025.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vermillion Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.